Search Results 1531-1540 of 21297 for anti-TNF drugs

1. Publications - Rashmi B. Halker Singh, M.D. - Mayo Clinic

   Risk of development of medication overuse headache with nonsteroidal anti-inflammatory drug therapy for migraine: a critically appraised topic. Neurologist ...

2. Pembrolizumab (Intravenous Route) Description and Brand Names - Mayo Clinic

   Pembrolizumab injection is also used alone as first-line treatment for stage III NSCLC in patients who cannot have surgery or chemotherapy with radiation or for ...

3. Propofol (Intravenous Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

4. A Study to Evaluate Comprehensive Arthroscopic Management (CAM) Procedure with Bone Marrow Aspirate Concentrate (BMAC) for Shoulder Osteoarthritis (OA) - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... therapy, and anti-inflammatory or injection therapy. Patients can provide ...

5. Study of DF9001 in Patients With Advanced Solid Tumors - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... Prior treatment with an anti-EGFR antibody is required for. RAS wild-type ...

6. Cytomegalovirus (CMV) Infection Clinical Trials - Mayo Clinic Research

   The purpose of this study is to evaluate the safety and effectiveness of the VERIS CMV Assay as an aid in the management of anti-CMV treatment for solid ...

7. Naltrexone And Bupropion (Oral Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

8. Androgen (Oral Route, Parenteral Route, Subcutaneous Route, Topical Application Route, Transdermal Route) Before Using - Mayo Clinic

   Allergies. Tell your doctor if you have ever had any unusual or allergic reaction to medicines in this group or any other medicines. Also tell your health care ...

9. Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy - Mayo Clinic

   About this study. Pazopanib is FDA approved as a second line and beyond treatment for metastatic soft tissue sarcoma. There is a population of elderly and ...

10. Spatial and Molecular Architecture of Tumor Environments Responsive to IO (immuno-oncology) Therapy - Mayo Clinic

    Recommendation by the treating provider to initiate therapy with a commercially available, FDA approved, anti-PD-1-based therapy or anti-PD-L1therapy; The ...